Smart Nanoparticle-Based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy

Area of Science:

• Biomedical Engineering
• Immunology
• Nanotechnology

Background:

• Tumor development and metastasis are intrinsically linked to the tumor microenvironment (TME).
• Modulating the TME is a key strategy for improving cancer immunotherapy efficacy.
• Nanoparticles (NPs) offer unique advantages for TME modulation and drug delivery.

Purpose of the Study:

• To review smart nanoparticle-based platforms for tumor microenvironment modulation.
• To discuss the composition of the TME and its cellular components.
• To highlight recent applications of NPs in cancer immunotherapy and clinical translation.

Main Methods:

• Review of current literature on smart NP platforms (responsive, targeting).
• Analysis of NP interactions with TME components (dendritic cells, macrophages, etc.).
• Discussion of NP-based strategies for enhancing cancer immunotherapy.

Main Results:

• Smart NPs demonstrate potential in delivering drugs and amplifying therapeutic effects within the TME.
• Various NP platforms can be designed to target specific TME components.
• NPs can initiate immune responses crucial for cancer immunotherapy.

Conclusions:

• Smart NP-based platforms are promising for regulating the TME and advancing cancer immunotherapy.
• Understanding TME composition is crucial for designing effective NP-based therapies.
• Further research is needed to address the advantages and disadvantages for clinical translation.